<p>聯合資本金融顧問公司在最近向證券交易委員會提交的 13F 文件中表示，在第四季度將其在美敦力公司的股份增加了 19.9%。該基金在季度內購買了 77,010 股後，持有 464,436 股這家醫療技術公司的股票。根據其最近的 SEC 文件，聯合資本金融顧問公司在美敦力的持股價值為 37,099,000 美元。</p>
<ul>
<li>MarketBeat 週報 – 02/17 - 02/21</li>
</ul>
<p>其他幾家對沖基金和機構投資者也對該公司的持倉進行了調整。Copley Financial Group Inc.在第三季度新購入了美敦力的股份，價值約為 694,000 美元。Franklin Street Advisors Inc. NC 在第四季度將其在美敦力的持股增加了 32.6%。Franklin Street Advisors Inc. NC 目前擁有 73,517 股這家醫療技術公司的股票，價值為 5,873,000 美元，此前在上個季度又購買了 18,057 股。Olstein Capital Management L.P.在第四季度將其在美敦力的持倉提高了 8.0%。Olstein Capital Management L.P.目前擁有 94,000 股這家醫療技術公司的股票，價值為 7,509,000 美元，此前在該期間又購買了 7,000 股。捷克國家銀行在第四季度將其在美敦力的持倉提高了 6.4%。捷克國家銀行目前擁有 278,065 股這家醫療技術公司的股票，價值為 22,212,000 美元，此前在該期間又購買了 16,786 股。最後，Empowered Funds LLC 在第四季度將其在美敦力的股份提高了 2.7%。Empowered Funds LLC 目前擁有 105,822 股這家醫療技術公司的股票，價值為 8,453,000 美元，此前在上個季度又購買了 2,778 股。82.06% 的股票由機構投資者持有。</p>
<h2>美敦力價格表現</h2>
<p>美敦力（NYSE:MDT）週二開盤價為 84.20 美元。該公司的市值為 1,079.9 億美元，市盈率為 25.59，市盈增長比率為 2.22，貝塔值為 0.79。該公司的 50 日簡單移動平均為 89.56 美元，200 日簡單移動平均為 87.60 美元。該公司的速動比率為 1.39，流動比率為 1.90，債務與股本比率為 0.48。美敦力的 12 個月低點為 75.96 美元，12 個月高點為 96.25 美元。</p>
<ul>
<li>美敦力的擴張勢頭增強——市場轉變的時機到了嗎？</li>
</ul>
<p>美敦力（NYSE:MDT - 獲取免費報告）最近於 2 月 18 日發佈了其財報。這家醫療技術公司報告第四季度每股收益為 1.39 美元，超出分析師一致預期的 1.36 美元，超出幅度為 0.03 美元。該季度的收入為 82.9 億美元，而分析師預期為 83.3 億美元。美敦力的淨利潤率為 12.83%，股本回報率為 14.07%。賣方分析師平均預測美敦力在當前年度的每股收益為 5.46。</p>
<h2>美敦力宣佈分紅</h2>
<p>該公司最近還披露了季度分紅，已於 4 月 11 日（星期五）支付。3 月 28 日（星期五）的股東獲得每股 0.70 美元的分紅。這相當於年化分紅為 2.80 美元，收益率為 3.33%。該分紅的除息日為 3 月 28 日（星期五）。美敦力的分紅支付比率為 85.11%。</p>
<h2>華爾街分析師預測增長</h2>
<ul>
<li>直覺外科在機器人手術創新中領先</li>
</ul>
<p>多位研究分析師對 MDT 股票發表了評論。Truist Financial 將美敦力的目標價從 93.00 美元下調至 90.00 美元，並在週五的報告中對該股票給予 “持有” 評級。Robert W. Baird 在 2 月 19 日的報告中將美敦力的目標價從 90.00 美元上調至 91.00 美元，並給予該股票 “中性” 評級。加拿大皇家銀行在 2 月 19 日的研究報告中重申了 “跑贏大盤” 評級，並對美敦力的股票設定了 105.00 美元的目標價。Needham &amp; Company LLC 在 2 月 19 日的研究報告中重申了對美敦力的 “持有” 評級。最後，花旗集團在 3 月 4 日的研究報告中將美敦力的評級從 “中性” 上調至 “買入”，並將該股票的目標價從 92.00 美元上調至 107.00 美元。一位研究分析師對該股票給予了 “賣出” 評級，八位分析師給予 “持有” 評級，六位分析師給予 “買入” 評級，還有一位分析師給予 “強烈買入” 評級。根據 MarketBeat.com 的數據，美敦力目前的共識評級為 “持有”，平均目標價為 96.14 美元。</p>
<p><strong>查看我們對美敦力的最新股票分析</strong></p>
<h2>內部活動</h2>
<p>在其他消息中，執行副總裁 Brett A. Wall 於 1 月 24 日（星期五）出售了 12,437 股公司的股票，交易價格為 90.00 美元，總價值為 1,119,330.00 美元。交易完成後，該執行副總裁目前直接持有 40,979 股公司的股票，價值為 3,688,110 美元。這代表其持股減少了 23.28%。該交易已在 SEC 的法律文件中披露，相關文件可通過此鏈接獲取。當前 0.20% 的股票由公司內部人士持有。</p>
<h2>美敦力公司簡介</h2>
<p>（免費報告）</p>
<p>美敦力公司開發、製造和銷售基於設備的醫療療法，服務於全球的醫療系統、醫生、臨牀醫生和患者。其心血管產品組合提供可植入的心臟起搏器、心臟復律除顫器和心臟再同步治療設備；心臟消融產品；可植入心臟監測系統；TYRX 產品；以及遠程監測和以患者為中心的軟件。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票，勝過美敦力</li>
<li>什麼是歐洲 STOXX 50 指數？</li>
<li>交易員再次開始押注 PayPal 的反彈</li>
<li>什麼是國債？</li>
<li>黑石是否在暗示儘管有新關税市場仍將反彈？</li>
<li>如何購買黃金股票並投資黃金</li>
<li>微軟：在關税擔憂中兼具增長與價值</li>
</ul>
<p><strong>想看看其他對美敦力持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com 獲取美敦力公司（NYSE:MDT - 免費報告）的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1000 美元在美敦力嗎？</h2>
<p>在考慮美敦力之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而美敦力並不在名單上。</p>
<p>雖然美敦力目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

美敦力

<p>United Capital Financial Advisors LLC 在第四季度將其在美敦力（Medtronic plc，NYSE:MDT）的持股增加了 19.9%，目前持有 464,436 股，價值 3710 萬美元。其他機構投資者也調整了他們的持倉，其中富蘭克林街顧問公司（Franklin Street Advisors）和奧爾斯坦資本管理公司（Olstein Capital Management）顯著增加了持股。美敦力的股票開盤價為 84.20 美元，市值為 1079.9 億美元。該公司報告每股收益為 1.39 美元，超出預期，並宣佈季度股息為每股 0.70 美元。分析師對該股票的評級不一，普遍評級為 “持有”</p>

<p>United Capital Financial Advisors LLC increased its stake in Medtronic plc (NYSE:MDT - Free Report) by 19.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 464,436 shares of the medical technology company's stock after buying an additional 77,010 shares during the quarter. United Capital Financial Advisors LLC's holdings in Medtronic were worth $37,099,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>聯合資本金融顧問公司在最近向證券交易委員會提交的 13F 文件中表示，在第四季度將其在美敦力公司的股份增加了 19.9%。該基金在季度內購買了 77,010 股後，持有 464,436 股這家醫療技術公司的股票。根據其最近的 SEC 文件，聯合資本金融顧問公司在美敦力的持股價值為 37,099,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 02/17 - 02/21</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週報 – 02/17 - 02/21</li>
</ul>
</div><p>Several other hedge funds and other institutional investors have also made changes to their positions in the company. Copley Financial Group Inc. acquired a new position in shares of Medtronic during the 3rd quarter worth approximately $694,000. Franklin Street Advisors Inc. NC increased its holdings in shares of Medtronic by 32.6% in the fourth quarter. Franklin Street Advisors Inc. NC now owns 73,517 shares of the medical technology company's stock valued at $5,873,000 after purchasing an additional 18,057 shares during the last quarter. Olstein Capital Management L.P. raised its position in shares of Medtronic by 8.0% in the fourth quarter. Olstein Capital Management L.P. now owns 94,000 shares of the medical technology company's stock valued at $7,509,000 after purchasing an additional 7,000 shares during the period. Czech National Bank raised its position in shares of Medtronic by 6.4% in the fourth quarter. Czech National Bank now owns 278,065 shares of the medical technology company's stock valued at $22,212,000 after purchasing an additional 16,786 shares during the period. Finally, Empowered Funds LLC lifted its stake in shares of Medtronic by 2.7% during the 4th quarter. Empowered Funds LLC now owns 105,822 shares of the medical technology company's stock worth $8,453,000 after buying an additional 2,778 shares during the last quarter. 82.06% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他幾家對沖基金和機構投資者也對該公司的持倉進行了調整。Copley Financial Group Inc.在第三季度新購入了美敦力的股份，價值約為 694,000 美元。Franklin Street Advisors Inc. NC 在第四季度將其在美敦力的持股增加了 32.6%。Franklin Street Advisors Inc. NC 目前擁有 73,517 股這家醫療技術公司的股票，價值為 5,873,000 美元，此前在上個季度又購買了 18,057 股。Olstein Capital Management L.P.在第四季度將其在美敦力的持倉提高了 8.0%。Olstein Capital Management L.P.目前擁有 94,000 股這家醫療技術公司的股票，價值為 7,509,000 美元，此前在該期間又購買了 7,000 股。捷克國家銀行在第四季度將其在美敦力的持倉提高了 6.4%。捷克國家銀行目前擁有 278,065 股這家醫療技術公司的股票，價值為 22,212,000 美元，此前在該期間又購買了 16,786 股。最後，Empowered Funds LLC 在第四季度將其在美敦力的股份提高了 2.7%。Empowered Funds LLC 目前擁有 105,822 股這家醫療技術公司的股票，價值為 8,453,000 美元，此前在上個季度又購買了 2,778 股。82.06% 的股票由機構投資者持有。</p>
</div><h2>Medtronic Price Performance</h2>
<div class="lb-trans"><h2>美敦力價格表現</h2>
</div><p>Shares of NYSE MDT opened at $84.20 on Tuesday. The company has a market capitalization of $107.99 billion, a PE ratio of 25.59, a P/E/G ratio of 2.22 and a beta of 0.79. The firm has a fifty day simple moving average of $89.56 and a 200 day simple moving average of $87.60. The company has a quick ratio of 1.39, a current ratio of 1.90 and a debt-to-equity ratio of 0.48. Medtronic plc has a twelve month low of $75.96 and a twelve month high of $96.25.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT）週二開盤價為 84.20 美元。該公司的市值為 1,079.9 億美元，市盈率為 25.59，市盈增長比率為 2.22，貝塔值為 0.79。該公司的 50 日簡單移動平均為 89.56 美元，200 日簡單移動平均為 87.60 美元。該公司的速動比率為 1.39，流動比率為 1.90，債務與股本比率為 0.48。美敦力的 12 個月低點為 75.96 美元，12 個月高點為 96.25 美元。</p>
</div><ul>
<li>Medtronic’s Expansion Gains Momentum—Time for a Market Shift?</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力的擴張勢頭增強——市場轉變的時機到了嗎？</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last posted its earnings results on Tuesday, February 18th. The medical technology company reported $1.39 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.03. The company had revenue of $8.29 billion for the quarter, compared to analyst estimates of $8.33 billion. Medtronic had a net margin of 12.83% and a return on equity of 14.07%. On average, sell-side analysts forecast that Medtronic plc will post 5.46 EPS for the current year.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT - 獲取免費報告）最近於 2 月 18 日發佈了其財報。這家醫療技術公司報告第四季度每股收益為 1.39 美元，超出分析師一致預期的 1.36 美元，超出幅度為 0.03 美元。該季度的收入為 82.9 億美元，而分析師預期為 83.3 億美元。美敦力的淨利潤率為 12.83%，股本回報率為 14.07%。賣方分析師平均預測美敦力在當前年度的每股收益為 5.46。</p>
</div><h2>Medtronic Announces Dividend</h2>
<div class="lb-trans"><h2>美敦力宣佈分紅</h2>
</div><p>The company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 3.33%. The ex-dividend date of this dividend was Friday, March 28th. Medtronic's dividend payout ratio is 85.11%.</p>
<div class="lb-trans"><p>該公司最近還披露了季度分紅，已於 4 月 11 日（星期五）支付。3 月 28 日（星期五）的股東獲得每股 0.70 美元的分紅。這相當於年化分紅為 2.80 美元，收益率為 3.33%。該分紅的除息日為 3 月 28 日（星期五）。美敦力的分紅支付比率為 85.11%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><ul>
<li>Intuitive Surgical Leads the Pack in Robotic Surgery Innovation</li>
</ul>
<div class="lb-trans"><ul>
<li>直覺外科在機器人手術創新中領先</li>
</ul>
</div><p>A number of research analysts have commented on MDT shares. Truist Financial decreased their price objective on Medtronic from $93.00 to $90.00 and set a &#34;hold&#34; rating on the stock in a report on Friday. Robert W. Baird raised their target price on shares of Medtronic from $90.00 to $91.00 and gave the stock a &#34;neutral&#34; rating in a report on Wednesday, February 19th. Royal Bank of Canada reiterated an &#34;outperform&#34; rating and issued a $105.00 price target on shares of Medtronic in a research note on Wednesday, February 19th. Needham &amp; Company LLC reiterated a &#34;hold&#34; rating on shares of Medtronic in a research report on Wednesday, February 19th. Finally, Citigroup upgraded Medtronic from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and raised their price target for the stock from $92.00 to $107.00 in a research report on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Medtronic presently has a consensus rating of &#34;Hold&#34; and an average target price of $96.14.</p>
<div class="lb-trans"><p>多位研究分析師對 MDT 股票發表了評論。Truist Financial 將美敦力的目標價從 93.00 美元下調至 90.00 美元，並在週五的報告中對該股票給予 “持有” 評級。Robert W. Baird 在 2 月 19 日的報告中將美敦力的目標價從 90.00 美元上調至 91.00 美元，並給予該股票 “中性” 評級。加拿大皇家銀行在 2 月 19 日的研究報告中重申了 “跑贏大盤” 評級，並對美敦力的股票設定了 105.00 美元的目標價。Needham &amp; Company LLC 在 2 月 19 日的研究報告中重申了對美敦力的 “持有” 評級。最後，花旗集團在 3 月 4 日的研究報告中將美敦力的評級從 “中性” 上調至 “買入”，並將該股票的目標價從 92.00 美元上調至 107.00 美元。一位研究分析師對該股票給予了 “賣出” 評級，八位分析師給予 “持有” 評級，六位分析師給予 “買入” 評級，還有一位分析師給予 “強烈買入” 評級。根據 MarketBeat.com 的數據，美敦力目前的共識評級為 “持有”，平均目標價為 96.14 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on Medtronic</strong></p>
<div class="lb-trans"><p><strong>查看我們對美敦力的最新股票分析</strong></p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部活動</h2>
</div><p>In other news, EVP Brett A. Wall sold 12,437 shares of the company's stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $90.00, for a total value of $1,119,330.00. Following the completion of the transaction, the executive vice president now directly owns 40,979 shares of the company's stock, valued at $3,688,110. This represents a 23.28 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.20% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他消息中，執行副總裁 Brett A. Wall 於 1 月 24 日（星期五）出售了 12,437 股公司的股票，交易價格為 90.00 美元，總價值為 1,119,330.00 美元。交易完成後，該執行副總裁目前直接持有 40,979 股公司的股票，價值為 3,688,110 美元。這代表其持股減少了 23.28%。該交易已在 SEC 的法律文件中披露，相關文件可通過此鏈接獲取。當前 0.20% 的股票由公司內部人士持有。</p>
</div><h2>Medtronic Company Profile</h2>
<div class="lb-trans"><h2>美敦力公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p>
<div class="lb-trans"><p>美敦力公司開發、製造和銷售基於設備的醫療療法，服務於全球的醫療系統、醫生、臨牀醫生和患者。其心血管產品組合提供可植入的心臟起搏器、心臟復律除顫器和心臟再同步治療設備；心臟消融產品；可植入心臟監測系統；TYRX 產品；以及遠程監測和以患者為中心的軟件。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>What is the Euro STOXX 50 Index?</li>
<li>Traders Started Betting on PayPal's Rally Again</li>
<li>What Are Treasury Bonds?</li>
<li>Is BlackRock Signaling a Market Rally Despite New Tariffs?</li>
<li>How to Buy Gold Stock and Invest in Gold</li>
<li>Microsoft: A Blend of Growth and Value Amid Tariff Concerns</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過美敦力</li>
<li>什麼是歐洲 STOXX 50 指數？</li>
<li>交易員再次開始押注 PayPal 的反彈</li>
<li>什麼是國債？</li>
<li>黑石是否在暗示儘管有新關税市場仍將反彈？</li>
<li>如何購買黃金股票並投資黃金</li>
<li>微軟：在關税擔憂中兼具增長與價值</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc (NYSE:MDT - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對美敦力持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com 獲取美敦力公司（NYSE:MDT - 免費報告）的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在美敦力嗎？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮美敦力之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而美敦力並不在名單上。</p>
</div><p>While Medtronic currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然美敦力目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

United Capital Financial Advisors LLC 在美敦力公司（NYSE:MDT）持有價值 3710 萬美元的股票頭寸